DE69940508D1 - Verfahren und zusammensetzung zur behandlung epidermaler irritationen und infektionen - Google Patents

Verfahren und zusammensetzung zur behandlung epidermaler irritationen und infektionen

Info

Publication number
DE69940508D1
DE69940508D1 DE69940508T DE69940508T DE69940508D1 DE 69940508 D1 DE69940508 D1 DE 69940508D1 DE 69940508 T DE69940508 T DE 69940508T DE 69940508 T DE69940508 T DE 69940508T DE 69940508 D1 DE69940508 D1 DE 69940508D1
Authority
DE
Germany
Prior art keywords
composition
infections
irritations
stannous fluoride
treating epidermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69940508T
Other languages
English (en)
Inventor
William J Embro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69940508D1 publication Critical patent/DE69940508D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
DE69940508T 1998-06-09 1999-06-09 Verfahren und zusammensetzung zur behandlung epidermaler irritationen und infektionen Expired - Lifetime DE69940508D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8856098P 1998-06-09 1998-06-09
PCT/US1999/013048 WO1999063816A1 (en) 1998-06-09 1999-06-09 Method and composition for the treatment of epidermal irritations and infections

Publications (1)

Publication Number Publication Date
DE69940508D1 true DE69940508D1 (de) 2009-04-16

Family

ID=22212082

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69940508T Expired - Lifetime DE69940508D1 (de) 1998-06-09 1999-06-09 Verfahren und zusammensetzung zur behandlung epidermaler irritationen und infektionen

Country Status (16)

Country Link
US (2) US6605289B1 (de)
EP (1) EP1085804B1 (de)
JP (1) JP2002517411A (de)
CN (1) CN1311628A (de)
AT (1) ATE424109T1 (de)
AU (1) AU760870B2 (de)
BR (1) BR9910981A (de)
CA (1) CA2334344C (de)
DE (1) DE69940508D1 (de)
EA (1) EA003463B1 (de)
ES (1) ES2323395T3 (de)
IL (1) IL140095A (de)
NZ (1) NZ509227A (de)
TR (1) TR200003674T2 (de)
WO (1) WO1999063816A1 (de)
ZA (1) ZA200100137B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040043047A1 (en) * 1999-03-26 2004-03-04 Parfums Christian Dior Cosmetic or dermatological compositions containing at least one substance for increasing the functionality and/or expression of the CD44 membrane receptors of skin cells
DE10033717A1 (de) * 2000-07-12 2002-01-24 Beiersdorf Ag Kosmetische und dermatologische Zubereitung zur Beseitigung von Sebum
US7879365B2 (en) 2002-02-07 2011-02-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
US7563461B2 (en) 2002-02-07 2009-07-21 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
JP4651944B2 (ja) * 2002-02-07 2011-03-16 ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 殺精子剤および殺菌剤からの粘膜刺激の予防のための亜鉛塩組成物
US7435429B2 (en) 2002-02-07 2008-10-14 Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
AU2003284337B2 (en) * 2002-10-25 2010-04-15 Precision Dermatology, Inc. Modulation of zinc levels to improve tissue properties
AU2003900064A0 (en) * 2003-01-09 2003-01-23 Penam Investments Pty. Ltd. A method of treatment or prophylaxis of viral infection.
TWI228051B (en) 2003-05-19 2005-02-21 Well Being Biochemical Corp Anti-bacterial, anti-viral, and anti-fungus composition, its preparation and use
US20060246148A1 (en) 2003-07-29 2006-11-02 Well-Being Biochemical Corp. Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use
CA2532730C (en) 2003-07-17 2013-02-26 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof
EP1576880A1 (de) * 2004-03-16 2005-09-21 Well-being Biochemical Corp. Bakterizide, viruzide und fungizide Zusammensetzung, deren Herstellung und Verwendung
US20070034118A1 (en) * 2005-08-12 2007-02-15 Jardine Leslie A Dosage efficient, storage stable compositions for reducing chromium (VI) in cement
GB0715141D0 (en) * 2007-08-03 2007-09-12 York Pharma Plc Improving skin barrier function
ES2618068T3 (es) * 2009-03-16 2017-06-20 Visions Marketing Group, Inc. Composición germicida
EP2283805A1 (de) 2009-07-28 2011-02-16 Sirvis BV Zusammensetzungen bestehend aus Zink, welches eine Verbindung in der hydrophoben Phase enthält
US20130236521A1 (en) * 2012-03-08 2013-09-12 Herpx Llc SnF2 APPLICATIONS, METHODS AND RELATED FORMULATIONS
BR112015011299A2 (pt) * 2012-11-20 2017-07-11 Onconox Aps saquinavir-no para imunomodulação
MX369505B (es) * 2012-12-19 2019-11-11 Colgate Palmolive Co Complejo de haluro de aminoácido y zinc con cisteína.
EP2934438B1 (de) 2012-12-19 2017-02-15 Colgate-Palmolive Company Zinkaminosäure-/trimethylglycinhalide
JP5968558B2 (ja) 2012-12-19 2016-08-10 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ 亜鉛リジン錯体
CA2892179C (en) 2012-12-19 2020-03-31 Colgate-Palmolive Company Composition with zinc amino acid/trimethylglycine halide precursors
MX352558B (es) 2012-12-19 2017-11-29 Colgate Palmolive Co Composiciones para el cuidado oral que contienen halogenuros de aminoácido de zinc.
US9504858B2 (en) 2012-12-19 2016-11-29 Colgate-Palmolive Company Zinc amino acid halide complex with cysteine
US9675823B2 (en) 2012-12-19 2017-06-13 Colgate-Palmolive Company Two component compositions containing zinc amino acid halide complexes and cysteine
MX352357B (es) 2012-12-19 2017-11-22 Colgate Palmolive Co Productos para el cuidado oral que contienen un complejo de zinc tetrabásico-aminoácido-halogenuro.
US9572756B2 (en) 2012-12-19 2017-02-21 Colgate-Palmolive Company Teeth whitening methods, visually perceptible signals and compositions therefor
US10188112B2 (en) 2012-12-19 2019-01-29 Colgate-Palmolive Company Personal cleansing compositions containing zinc amino acid/trimethylglycine halide
MX353019B (es) 2012-12-19 2017-12-18 Colgate Palmolive Co Enjuagues bucales de haluros de aminoácidos y zinc.
RU2628540C2 (ru) 2012-12-19 2017-08-18 Колгейт-Палмолив Компани Продукты для ухода за полостью рта, включающие оксид цинка и триметилглицин
EP2934441B1 (de) 2012-12-19 2017-04-26 Colgate-Palmolive Company Orales gel mit einem zinkaminosäurekomplex
BR112015014453B1 (pt) 2012-12-19 2019-06-11 Colgate-Palmolive Company Composição para higiene oral, complexo iônico, usos de um haleto de zinco tetrabásico em conjunto com trimetilglicina na forma de sal de adição de ácido e complexo
EP2934695B1 (de) 2012-12-19 2016-11-30 Colgate-Palmolive Company Schweisshemmende mittel mit protein und antiperspirantsalzen
US9498421B2 (en) 2012-12-19 2016-11-22 Colgate-Palmolive Company Two component compositions containing tetrabasic zinc-amino acid halide complexes and cysteine
US9750670B2 (en) 2012-12-19 2017-09-05 Colgate-Palmolive Company Zinc amino acid complex with cysteine
EP3380064B1 (de) 2015-12-30 2020-05-06 Colgate-Palmolive Company Kosmetische formulierungen
MX370240B (es) * 2015-12-30 2019-12-06 Colgate Palmolive Co Composiciones para el cuidado personal.
CN117618259A (zh) 2018-03-29 2024-03-01 宝洁公司 用于促进牙龈健康的口腔护理组合物
CN109381357B (zh) * 2018-12-13 2021-09-03 广州宝莱生物科技有限公司 一种祛痘润肤水蛭冻干粉
WO2021067992A1 (en) 2019-09-30 2021-04-08 The Procter & Gamble Company Methods of use of oral care compositions comprising hops
BR112022004332A2 (pt) 2019-09-30 2022-05-31 Procter & Gamble Composições dentifrícias para o tratamento de biofilme dental
CA3155865A1 (en) 2019-09-30 2021-04-08 The Procter & Gamble Company TOOTHPASTE COMPOSITIONS FOR TREATING DENTAL BIOFILM
WO2021062607A1 (en) 2019-09-30 2021-04-08 The Procter & Gamble Company Oral care compositions comprising hops beta acid and amino acid

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2749213A (en) * 1952-07-03 1956-06-05 American Home Prod Stannous fluoro complex salts
US3282792A (en) * 1964-01-09 1966-11-01 Bristol Myers Co Stabilized stannous fluoride dentifrice compositions
US4097590A (en) * 1975-07-24 1978-06-27 Geraldine Fay Weisz Methods and compositions for treatment of bacterial and fungus infections of the skin
US4138477A (en) * 1976-05-28 1979-02-06 Colgate Palmolive Company Composition to control mouth odor
US4267164A (en) * 1980-01-31 1981-05-12 Block Drug Company Inc. Effervescent stannous fluoride tablet
AU548560B2 (en) * 1980-05-20 1985-12-19 Vipont Laboratories Inc. Benzophenanthridine alkaloids as antimicrobial agents
US4406881A (en) * 1980-05-20 1983-09-27 Vipont Laboratories Antimicrobial agent
US4383990A (en) * 1980-10-01 1983-05-17 Beecham Group Limited Antiviral agents, their preparation and use
US4469674A (en) * 1981-09-03 1984-09-04 Richardson-Vicks Inc. Stable oral compositions containing zinc and fluoride compounds
US4415590A (en) * 1982-04-26 1983-11-15 Betamed Pharmaceuticals, Inc. Herpes treatment
US4419346A (en) * 1982-08-13 1983-12-06 Nabisco Brands, Inc. Method and composition to inhibit the growth of Streptococcus mutans by the use of saccharin/fluoride combination
US4431631A (en) * 1983-01-03 1984-02-14 Colgate-Palmolive Company Aqueous oral solution
US4568540A (en) * 1984-04-18 1986-02-04 Johnson & Johnson Oral hygiene compositions
GB2179536B (en) * 1984-06-11 1988-12-21 Godfrey Science & Design Inc Improvement in the flavour of zinc supplements for oral use
US4664906A (en) * 1984-08-30 1987-05-12 Johnson & Johnson Products Inc. Oral compositions
US4684517A (en) * 1985-02-04 1987-08-04 Colgate-Palmolive Company Mouthrinse composition containing hydrogen peroxide and fluoride
US4765984A (en) * 1986-01-22 1988-08-23 Colgate-Palmolive Company Stable single unit dose oral product
US4952392A (en) * 1986-03-17 1990-08-28 Peri-Oral Dental Products, Inc. Use of periwinkle in oral hygiene
US5004597A (en) * 1987-09-14 1991-04-02 The Procter & Gamble Company Oral compositions comprising stannous flouride and stannous gluconate
US5098716A (en) * 1990-08-23 1992-03-24 Embro William J Method and composition for treating diseases having a viral etiology
US5094845A (en) * 1991-03-04 1992-03-10 David G. Vlock Oral compositions containing zinc gluconate complexes
US5416075A (en) 1993-11-30 1995-05-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Biospecific emulsions
US5708023A (en) * 1994-03-28 1998-01-13 The Trustees Of Columbia University In The City Of New York Zinc gluconate gel compositions
EP0691124A1 (de) * 1994-07-07 1996-01-10 Sara Lee/DE N.V. Mundpflegemittel
CN1115620A (zh) * 1994-07-26 1996-01-31 袁升彪 婴幼儿童饮用水
US5624906A (en) * 1994-12-08 1997-04-29 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
DE69528445D1 (de) 1994-12-12 2002-11-07 Unilever Nv Anti-mikrobielles Mittel
US5658946A (en) * 1996-05-29 1997-08-19 The Procter & Gamble Company Methods for the treatment of herpes virus infections
US5908640A (en) * 1997-07-25 1999-06-01 Embro; William J. Veterinary compositions for treating epidermal irritations

Also Published As

Publication number Publication date
CA2334344C (en) 2005-08-16
IL140095A0 (en) 2002-02-10
WO1999063816A1 (en) 1999-12-16
EP1085804A4 (de) 2005-09-28
EA003463B1 (ru) 2003-06-26
EP1085804B1 (de) 2009-03-04
TR200003674T2 (tr) 2001-07-23
US20040042978A1 (en) 2004-03-04
CA2334344A1 (en) 1999-12-16
CN1311628A (zh) 2001-09-05
BR9910981A (pt) 2004-08-03
AU760870B2 (en) 2003-05-22
US6605289B1 (en) 2003-08-12
ZA200100137B (en) 2001-07-10
AU4558399A (en) 1999-12-30
EA200100015A1 (ru) 2001-06-25
IL140095A (en) 2005-11-20
EP1085804A1 (de) 2001-03-28
NZ509227A (en) 2003-08-29
ES2323395T3 (es) 2009-07-14
ATE424109T1 (de) 2009-03-15
JP2002517411A (ja) 2002-06-18

Similar Documents

Publication Publication Date Title
ATE424109T1 (de) Verfahren und zusammensetzung zur behandlung epidermaler irritationen und infektionen
DE69827664D1 (de) Thioharnstoffverbindungen, zusammensetzungen sowie verfahren zur behandlung oder verhütung von entzündlichen erkrankungen und atherosklerose
BRPI0309769B8 (pt) composição lubrificante substancialmente anidra
DK0880350T3 (da) Behandling af dissemineret sklerose
HUP0202853A2 (hu) A retigabin alkalmazása neuropátiás fájdalom kezelésére
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
DE602004003587D1 (de) Kosmetische verwendung einer zusammensetzung mit mindestens einem oxazolin als wirkstoff, als abnehmprodukt und/oder zur prävention und/oder behandlung von cellulite
DE69735090D1 (de) Neurotrophin antagoniste zur behandlung von der epilepsie, alzheimer'schen krankheit und schmerzen
DE69905616T2 (de) Verfahren und zusammensetzung zur behandlung und vorbeugung von mycobacterium infektionen
NZ506681A (en) Disinfecting composition
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE69626311D1 (de) Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
WO2004004645A3 (en) Composition for lessening malodors during hair treatment and hair removal and method of use
ATE287713T1 (de) Verwendung von riluzol zur behandlung multipler sklerose
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
GB2343844B (en) Composition and method for treatment of hypertrophic skin accumlations and their prevention
PL348721A1 (en) Use of phosphonoformic acid derivatives for treating infections
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE69905263T2 (de) Verfahren zur dekorativen behandlung von oberflächen
ATE316385T1 (de) Zusammensetzungen zur behandlung und vorbeugung von atherosklerose
ATE291434T1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
DE69913051D1 (de) Verfahren zur Behandlung und Entsorgung von einer Epithio-Verbindung
PL348354A1 (en) Use of phosphonoformic acid derivatives for treating infections
DE60233353D1 (de) Verfahren zur behandlung von halitose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition